• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor.

作者信息

Della-Torre Emanuel, Conti Antonio, Berti Alvise, Yacoub Mona Rita, Alessio Massimo

机构信息

Università Vita-Salute San Raffaele, School of Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Unit of Medicine and Clinical immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Int J Rheum Dis. 2017 Feb;20(2):276-279. doi: 10.1111/1756-185X.13021. Epub 2016 Dec 30.

DOI:10.1111/1756-185X.13021
PMID:28036157
Abstract
摘要

相似文献

1
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor.IgG4相关疾病中的利妥昔单抗超敏反应：1例伴有IgG4类风湿因子患者的成功脱敏治疗
Int J Rheum Dis. 2017 Feb;20(2):276-279. doi: 10.1111/1756-185X.13021. Epub 2016 Dec 30.
2
Hypersensitivity reactions to rituximab: 53 successful desensitizations in 7 patients with severe, near-fatal reactions.利妥昔单抗超敏反应：7例严重、近乎致命反应患者中的53次成功脱敏。
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):1000-2. doi: 10.1016/j.jaip.2016.05.013. Epub 2016 Jun 18.
3
Predictors of disease relapse in IgG4-related disease following rituximab.利妥昔单抗治疗后IgG4相关疾病疾病复发的预测因素。
Rheumatology (Oxford). 2016 Jun;55(6):1000-8. doi: 10.1093/rheumatology/kev438. Epub 2016 Feb 16.
4
[Rituximab therapy for relapsing IgG4-autoimmune pancreatitis and cholangitis - a case report].利妥昔单抗治疗复发性IgG4自身免疫性胰腺炎和胆管炎——病例报告
Z Gastroenterol. 2015 Jan;53(1):40-2. doi: 10.1055/s-0034-1385717. Epub 2015 Jan 16.
5
Desensitization to rituximab in a multidisciplinary setting.多学科环境下对利妥昔单抗的脱敏治疗
Int J Clin Pharm. 2015 Oct;37(5):744-8. doi: 10.1007/s11096-015-0136-x. Epub 2015 May 22.
6
Rituximab desensitization in two patients with muscle-specific kinase myasthenia gravis.两名肌肉特异性激酶重症肌无力患者的利妥昔单抗脱敏治疗
Muscle Nerve. 2019 Nov;60(5):E35-E37. doi: 10.1002/mus.26691. Epub 2019 Sep 11.
7
Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.利妥昔单抗过敏反应：评估、脱敏及潜在机制。
J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1564-1571. doi: 10.1016/j.jaip.2017.08.004.
8
Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.利妥昔单抗用于24例患者的快速药物脱敏：单中心经验
J Investig Allergol Clin Immunol. 2019;29(6):468-470. doi: 10.18176/jiaci.0445. Epub 2019 Sep 18.
9
[New strategies for the treatment of IgG4-related disease].[IgG4相关疾病的治疗新策略]
Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(6):485-490. doi: 10.2177/jsci.39.485.
10
Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.利妥昔单抗治疗的爱泼斯坦-巴尔病毒相关B细胞淋巴增殖性疾病合并免疫球蛋白G4相关疾病的良好结局：病例报告
J Med Case Rep. 2016 Aug 24;10(1):236. doi: 10.1186/s13256-016-1009-1.

引用本文的文献

1
A case report of IgG4-RD involving bilateral renal pelvis and literature review.一例累及双侧肾盂的IgG4相关性疾病病例报告及文献复习
Medicine (Baltimore). 2025 Aug 15;104(33):e43453. doi: 10.1097/MD.0000000000043453.
2
Discriminative features of immunoglobulin G4-related disease (IgG4-RD) and associated autoimmune rheumatic diseases (ARDs) in a nationwide observational cohort: study from the Egyptian College of Rheumatology.全国性观察队列中免疫球蛋白G4相关疾病（IgG4-RD）及相关自身免疫性风湿性疾病（ARDs）的鉴别特征：来自埃及风湿病学会的研究
Clin Rheumatol. 2025 Feb;44(2):747-756. doi: 10.1007/s10067-024-07274-y. Epub 2025 Jan 3.
3
Desensitization to biological agents used in rheumatology.
对风湿病学中使用的生物制剂的脱敏作用。
Reumatologia. 2020;58(1):25-33. doi: 10.5114/reum.2020.93510. Epub 2020 Feb 28.
4
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.利妥昔单抗治疗IgG4相关疾病的长期疗效及安全性：来自法国一项33例患者的全国性研究数据
PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.